title: Postprandial lipemia is modified by the presence of the APOB-516C/T polymorphism in a healthy Caucasian population.
abstract: Apolipoprotein (apoB) plays a fundamental role in the transport and metabolism of plasma triacylglycerols (TAGs) and cholesterol. Several apoB polymorphic sites have been studied for their potential use as markers for coronary heart disease in the population. In view of the importance of apoB in postprandial metabolism, our objective was to determine whether the presence of the -516C/T polymorphism in the APOB gene promoter could influence postprandial lipoprotein metabolism in healthy subjects. Forty-seven volunteers who were homozygous for the E3 allele at the APOE gene were selected (30 homozygous for the common genotype (C/C) and 17 heterozygotes for the -516T allele (C/T). They were given a fat-rich meal containing 1 g fat and 7 mg cholesterol per kg body weight and vitamin A 60,000 IU/m(2) body surface. Fat accounted for 60% of calories, and protein and carbohydrates for 15 and 25% of energy, respectively. Blood samples were taken at time 0, every 1 h until 6 h, and every 2.5 h until 11 h. Total cholesterol and TAGs in plasma, and cholesterol, TAGs and retinyl palmitate in triacylglycerol-rich lipoproteins (large and small triacylglycerol-rich lipoproteins) were determined by ultracentrifugation. Individuals carrying the C/T genotype presented greater postprandial concentrations of TAGs in small triacylglycerol-rich lipoproteins than did carriers of the C/C genotype (P = 0.022). Moreover, C/T individuals presented higher concentrations of plasma TAGs during the postprandial period than did C/C subjects (P = 0.039). No other statistically significant genotype-related differences for other parameters were observed. These results suggest that the presence of the genotype C/T is associated with a higher postprandial response. Thus, the allele variability in the -516C/T polymorphism in the APOB gene promoter may partly explain the interindividual differences in postprandial lipemic response in healthy subjects.
authors: Unit of Lipids and Atherosclerosis, Hospital Universitario Reina Sofia, Avda. Menéndez Pidal, Cordoba, Spain. pablopermar@yahoo.es
authors: Pablo
authors: P
authors: Pérez-Martínez
authors: Francisco
authors: F
authors: Pérez-Jiménez
authors: José María
authors: JM
authors: Ordovás
authors: Juan Antonio
authors: JA
authors: Moreno
authors: Carmen
authors: C
authors: Marín
authors: Rafael
authors: R
authors: Moreno
authors: Yolanda
authors: Y
authors: Jiménez-Gómez
authors: Juan Antonio
authors: JA
authors: Paniagua
authors: José
authors: J
authors: López-Miranda
mesh_terms: D000293:Adolescent; D000328:Adult; D053299:Apolipoprotein B-100 / Q000097:blood; D053283:Apolipoprotein B-48 / Q000097:blood; D001055:Apolipoproteins B / Q000235:genetics*; D002784:Cholesterol / Q000097:blood; D004591:Electrophoresis, Polyacrylamide Gel; D005838:Genotype; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000235:genetics*; D008055:Lipids / Q000097:blood; D008297:Male; D011110:Polymorphism, Genetic; D019518:Postprandial Period; D014280:Triglycerides / Q000097:blood; D044465:White People / Q000235:genetics*
chemical_list: D053299:Apolipoprotein B-100; D053283:Apolipoprotein B-48; D001055:Apolipoproteins B; D008055:Lipids; D014280:Triglycerides; D002784:Cholesterol